A LinkedIn post from Healthera highlights what it describes as underused private treatment revenue streams for community pharmacies. The post suggests that many pharmacies already have the capability to offer such services but lack visibility, easy booking, and active promotion.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, the average Healthera pharmacy generates more than £4,200 from private treatments, with some operators reportedly not yet having a dedicated treatments page. Demand is portrayed as robust, supported by NHS England data citing millions of consultations delivered through community pharmacies each year.
The post points to weight-loss services, hair loss and acne treatments, and broader men’s and women’s health offerings as key private categories with recurring or repeat-purchase characteristics and attractive margins. It frames the main barrier as accessibility rather than demand, emphasizing the need for streamlined digital pathways.
Healthera’s LinkedIn content positions the Healthera Clinic platform as an end-to-end solution for private treatments, including online discovery, digital consultations, booking, payments, patient communication, and repeat reminders. For investors, this suggests a strategic focus on monetizing the shift toward clinical and private services in community pharmacy through SaaS-style tools that could drive higher revenue per pharmacy customer.
If adoption and demonstrated uplift in private treatment income scale across a broader customer base, Healthera could enhance its recurring revenue profile and strengthen retention by embedding itself in core pharmacy workflows. The emphasis on high-demand categories such as weight loss and chronic dermatological and hormonal issues may also provide exposure to structurally growing segments of the healthcare services market.